CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2025	Dec. 29, 2024
Operating Activities:
Net income	$ 3,004	$ 3,180
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	393	436
Income tax provision in excess of income tax payments	291	247
Share-based compensation expense	888	759
Net gains on marketable securities and other investments	(165)	(45)
Other items	(40)	(23)
Changes in assets and liabilities:
Accounts receivable, net	243	392
Inventories	(99)	111
Other assets	553	148
Trade accounts payable	(73)	11
Payroll, benefits and other liabilities	100	(541)
Unearned revenues	(130)	(88)
Net cash provided by operating activities	4,965	4,587
Investing Activities:
Capital expenditures	(549)	(277)
Purchases of debt and equity marketable securities	(883)	(914)
Proceeds from sales and maturities of debt and equity marketable securities	767	752
Acquisitions and other investments, net of cash acquired	(1,090)	(260)
Other items	34	28
Net cash used by investing activities	(1,721)	(671)
Financing Activities:
Proceeds from short-term debt	0	500
Repayment of short-term debt	0	(500)
Repurchases and retirements of common stock	(2,650)	(1,750)
Dividends paid	(949)	(942)
Payments of tax withholdings related to vesting of share-based awards	(280)	(315)
Other items	(3)	(1)
Net cash used by financing activities	(3,882)	(3,008)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	(44)
Net (decrease) increase in total cash, cash equivalents and restricted cash	(638)	864
Total cash and cash equivalents at beginning of period (including $2,323 classified as restricted cash at September 28, 2025)	7,843	7,849
Total cash and cash equivalents at end of period	7,205	$ 8,713
Beginning Balance - Restricted Cash	2,323
Ending Balance - Restricted Cash	$ 0